SETBP1 mutations have also been identified in solid tumors including pancreatic neuroendocrine tumors, breast cancer, non‐small cell lung cancer, and gastric cancer (Ban et al., 2022; Coudray et al., 2018; Glentis et al., 2019; Zhang et al., 2019). Here, SETBP1 is linked to breast cancer.